ClinVar Miner

Submissions for variant NM_024301.5(FKRP):c.1177G>A (p.Val393Ile)

gnomAD frequency: 0.00150  dbSNP: rs140679502
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000192864 SCV000168555 likely benign not specified 2018-02-27 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Genetic Services Laboratory, University of Chicago RCV000192864 SCV000247378 uncertain significance not specified 2014-07-08 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000192864 SCV000335985 likely benign not specified 2015-10-02 criteria provided, single submitter clinical testing
Invitae RCV000456138 SCV000559439 likely benign Walker-Warburg congenital muscular dystrophy 2024-01-31 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV001093246 SCV000613306 uncertain significance not provided 2020-02-17 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001093246 SCV001250137 uncertain significance not provided 2019-12-01 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001093246 SCV002048979 uncertain significance not provided 2023-10-20 criteria provided, single submitter clinical testing The FKRP c.1177G>A; p.Val393Ile variant (rs140679502), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 137380). This variant is found in the African population with an allele frequency of 0.7% (162/24462 alleles, including 1 homozygote) in the Genome Aggregation Database. The valine at codon 393 is highly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.66). Due to limited information, the clinical significance of the p.Val393Ile variant is uncertain at this time. Gene specific statement: Pathogenic variants in FKRP are inherited in an autosomal recessive manner and are associated with muscular dystrophy-dystroglycanopathy types A5, B5 and C5 (MIM: 613153, 606612, and 607155). Symptomatic heterozygous carriers have also been reported at least once in the literature and present with a milder phenotype (Schottlaender et al. 2015).
Ambry Genetics RCV002336274 SCV002639713 benign Cardiovascular phenotype 2019-01-29 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Duke University Health System Sequencing Clinic, Duke University Health System RCV001275320 SCV003919050 likely benign Autosomal recessive limb-girdle muscular dystrophy type 2I 2023-04-20 criteria provided, single submitter research
Mayo Clinic Laboratories, Mayo Clinic RCV001093246 SCV004225417 uncertain significance not provided 2023-04-18 criteria provided, single submitter clinical testing BS1
PreventionGenetics, part of Exact Sciences RCV003925237 SCV004750943 likely benign FKRP-related condition 2019-06-11 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Natera, Inc. RCV001275320 SCV001460345 benign Autosomal recessive limb-girdle muscular dystrophy type 2I 2020-01-10 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.